WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998016235) PERIPHERAL BLOOD STEM CELL-INCREASING AGENTS CONTAINING GLYCOSIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/016235    International Application No.:    PCT/JP1997/003698
Publication Date: 23.04.1998 International Filing Date: 14.10.1997
Chapter 2 Demand Filed:    08.05.1998    
IPC:
A61K 38/00 (2006.01), A61K 38/19 (2006.01), C07H 15/04 (2006.01), C07K 14/535 (2006.01)
Applicants: KIRIN BREWERY COMPANY, LIMITED [JP/JP]; 10-1, Shinkawa 2-chome, Chuo-ku, Tokyo 104 (JP) (For All Designated States Except US).
KOEZUKA, Yasuhiko [JP/JP]; (JP) (For US Only).
MOTOKI, Kazuhiro [JP/JP]; (JP) (For US Only)
Inventors: KOEZUKA, Yasuhiko; (JP).
MOTOKI, Kazuhiro; (JP)
Agent: HIRAKI, Yusuke; Toranomon No.5 Mori Building, 3rd floor, 17-1, Toranomon 1-chome, Minato-ku, Tokyo 105-0001 (JP)
Priority Data:
8/291148 14.10.1996 JP
Title (EN) PERIPHERAL BLOOD STEM CELL-INCREASING AGENTS CONTAINING GLYCOSIDES
(FR) AGENTS AUGMENTANT LE NOMBRE DE CELLULES SOUCHES DU SANG PERIPHERIQUE ET CONTENANT DES GLUCOSIDES
Abstract: front page image
(EN)Peripheral blood stem cell-increasing agents to be used in the peripheral blood stem cell transplantation therapy with the use of G-CSF, which contain as the active ingredient at least one glycoside compound represented by general formula (A) or its salt preferably exemplified by (2S,3S,4R)-1-($g(a)-D-galactopyranosyloxy)-2-hexacosanoylamino-3,4-octadecanediol; and medicinal compositions or medicinal kits for increasing peripheral blood stem cells which contain these agents together with G-CSF.
(FR)Agents augmentant le nombre de cellules souches du sang périphérique, qui peuvent être utilisés dans les greffes de cellules souches du sang périphérique utilisant le G-CSF, et qui contiennent comme principe actif au moins un composé glucoside représenté par la formule générale (A) ou son sel, de préférence le (2S,3S,4R)-1-($g(a)-D-galactopyranosiloxy)-2-hexacosanoylamino-3,4-octadécanediol; et compositions médicales ou trousses médicales destinées à augmenter le nombre de cellules souches du sang périphérique, qui contiennent lesdits agents associés au G-CSF.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)